These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7213531)

  • 1. Effect of naproxen on glucose metabolism and tolbutamide kinetics and dynamics in maturity onset diabetics.
    Whiting B; Williams RL; Lorenzi M; Varady JC; Robins DS
    Br J Clin Pharmacol; 1981 Mar; 11(3):295-302. PubMed ID: 7213531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction between naproxen and tolbutamide on metabolism in diabetics].
    Sachse G; Willms B; Becker R
    Arzneimittelforschung; 1979; 29(5):835-6. PubMed ID: 582983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of diclofenac sodium on the metabolism of diabetics in qualitative diet therapy with an without tolbuamide. A clinically oriented study in aged diabetics with rheumatic disease].
    Schlumpf U
    Schweiz Med Wochenschr; 1978 Jan; 108(1):28-34. PubMed ID: 304247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the question of an interaction between sulindac and tolbutamide in the control of diabetes.
    Ryan JR; Jain AK; McMahon FG; Vargas R
    Clin Pharmacol Ther; 1977 Feb; 21(2):231-3. PubMed ID: 837641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus.
    Ferrari C; Romussi M; Bertazzoni A; Testori GP; Grimaldi MG
    Biomedicine; 1978 Jun; 29(4):133-6. PubMed ID: 556385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective acute insulin secretion in diabetics. Differences between normal weight and obese subjects.
    Vague P; Ramahandridona G; Vialettes B; Raymond JP; Vague J
    Diabete Metab; 1978 Dec; 4(4):261-5. PubMed ID: 729892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus.
    Pfeifer MA; Halter JB; Beard JC; Porte D
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1256-62. PubMed ID: 7028776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL; Nakasone K; Pasternak K
    Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of food on the bioavailability and pharmacodynamics of tolbutamide in diabetic patients.
    Antal EJ; Gillespie WR; Phillips JP; Albert KS
    Eur J Clin Pharmacol; 1982; 22(5):459-62. PubMed ID: 6749526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and non-esterified fatty acid metabolism in asymptomatic diabetics and atherosclerotic subjects.
    Kashyap ML; Magill F; Rojas L; Hoffman MM
    Can Med Assoc J; 1970 May; 102(11):1165-9. PubMed ID: 5420996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of diabetes mellitus on drug metabolism in man.
    Daintith H; Stevenson IH; O'Malley K
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):55-8. PubMed ID: 1248919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of induction of liver microsomal enzymes by tolbutamide in maturity-onset diabetics.
    Redman DR; Prescott LF
    Diabetes; 1973 Mar; 22(3):210-1. PubMed ID: 4689295
    [No Abstract]   [Full Text] [Related]  

  • 14. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes mellitus. Distinguishing between patients receiving insulin and those requiring insulin therapy.
    Mahler RJ
    West J Med; 1974 May; 120(5):358-62. PubMed ID: 4839480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolbutamide for maturity-onset diabetics: a clinical comparison of a single-dose versus a divided-dose schedule.
    Vinik AI; Jackson WP; Marine N; Saxe N
    S Afr Med J; 1968 Dec; 42(46):1257-8. PubMed ID: 5720132
    [No Abstract]   [Full Text] [Related]  

  • 18. [Insulin-sensitivity and insulin-insensitivity in Indian diabetics as determined by the insulin tolerance test and their influence on the therapeutic response to tolbutamide].
    Singh I; Srivastava MC
    Acta Diabetol Lat; 1970; 7(5):767-76. PubMed ID: 5526500
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of maturity-onset diabetes mellitus resistant to insulin but responsive to tolbutamide.
    Rendell M; Slevin D; Meltz G; Simpson J; Barquet A
    Ann Intern Med; 1979 Feb; 90(2):195-7. PubMed ID: 443652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proportion of low insulin responders to glucose among the offspring of maturity-onset diabetics (author's transl)].
    Vague P; Ramahandridona G; Vague J
    Diabete Metab; 1975 Mar; 1():45-50. PubMed ID: 1234066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.